News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clovis Oncology (CLVS) Announces Sale Of Shares Of Common Stock By Selling Stockholders



12/4/2013 9:07:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) announced today the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a price to the public of $57.50 per share. All of the shares are being sold by certain existing stockholders who acquired the shares of the Company’s common stock as consideration in connection with the Company’s acquisition of EOS (Ethical Oncology Science) S.p.A.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES